Lexiva Prescribing Information from the FDA Web site [PDF]. A more current version may be available on the manufacturer's Web site.
PMID/15748098 Arvieux C, Tribut O. Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile. Drugs. 2005;65(5):633-59. Review.
PMID/12871195 Vierling P, Greiner J. Prodrugs of HIV protease inhibitors. Curr Pharm Des 2003;9(22):1755-70.
PMID/16861096 Gathe JC Jr, Wood R, Sanne I, DeJesus E, Schürmann D, Gladysz A, Garris C, Givens N, Elston R, Yeo J. Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study. Clin Ther. 2006 May;28(5):745-54.
PMID/18663041 Calza L, Manfredi R, Pocaterra D, Chiodo F. Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. Int J STD AIDS. 2008 Aug;19(8):541-4.
PMID/19151039 Gatti F, Nasta P, Loregian A, Puoti M, Matti A, Pagni S, Gonzalez de Requena D, Prestini K, Parisi SG, Bonora S, Palù G, Carosi G. Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis. J Antimicrob Chemother. 2009 Jan 16. [Epub ahead of print].
PMID/18852278 Marcelin AG, Flandre P, Molina JM, Katlama C, Yeni P, Raffi F, Antoun Z, Ait-Khaled M, Calvez V.Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials. Antimicrob Agents Chemother. 2008 Dec;52(12):4251-7. Epub 2008 Oct 13.
|
[1] FDA - Lexiva Prescribing Information, 03/05/08, p. 18. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [2] FDA - Drugs Used in the Treatment of HIV Infection. Available at: http://www.fda.gov/oashi/aids/virals.html. Accessed 01/19/09. [3] AHFS Drug Information - 2008; p. 648 [4] AHFS Drug Information - 2008; p. 648 [5] FDA - Lexiva Prescribing Information, 03/05/08, p. 38. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [6] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [7] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [8] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [9] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [10] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [11] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [12] FDA - Lexiva Prescribing Information, 03/05/08, p. 43. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [13] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [14] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [15] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [16] FDA - Lexiva Prescribing Information, 03/05/08, p. 38. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [17] FDA - Lexiva Prescribing Information, 03/05/08, p. 38. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [18] FDA - Lexiva Prescribing Information, 03/05/08, p. 32. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [19] FDA - Lexiva Prescribing Information, 03/05/08, pp. 19, 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [20] FDA - Lexiva Prescribing Information, 03/05/08, p. 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [21] FDA - Lexiva Prescribing Information, 03/05/08, p. 20. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [22] FDA - Lexiva Prescribing Information, 03/05/08, p. 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [23] FDA - Lexiva Prescribing Information, 03/05/08, p. 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [24] FDA - Lexiva Prescribing Information, 03/05/08, p. 37. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [25] FDA - Lexiva Prescribing Information, 03/05/08, p. 38. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [26] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [27] FDA - Lexiva Prescribing Information, 03/05/08, p. 17. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [28] FDA - Lexiva Prescribing Information, 03/05/08, pp. 32-3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [29] Pharm GKB - The Pharmacogenetics and Pharmacogenomics Knowledge Base - fosamprenavir. Available at: http://www.pharmgkb.org. Accessed 01/19/09. [30] FDA - Lexiva Prescribing Information, 03/05/08, p. 10. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [31] FDA - Lexiva Prescribing Information, 03/05/08, pp. 5, 8. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [32] FDA - Lexiva Prescribing Information, 03/05/08, p. 6. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [33] FDA - Lexiva Prescribing Information, 03/05/08, pp. 5-6. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [34] FDA - Lexiva Prescribing Information, 03/05/08, p. 6. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [35] FDA - Lexiva Prescribing Information, 03/05/08, p. 6. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [36] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [37] FDA - Lexiva Prescribing Information, 03/05/08, p. 21. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [38] FDA - Lexiva Prescribing Information, 03/05/08, p. 2. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [39] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [40] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [41] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [42] FDA - Lexiva Prescribing Information, 03/05/08, p. 13. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [43] FDA - Lexiva Prescribing Information, 03/05/08, p. 13. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [44] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [45] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [46] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [47] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [48] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [49] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [50] Wolters Kluwer Health, Inc. - Fosamprenavir, Facts and Comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed 01/19/09. [51] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [52] FDA - Lexiva Prescribing Information, 03/05/08, p. 5. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [53] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 01/19/09. [54] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 01/19/09. [55] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 01/19/09. [56] Calculation. - [57] Merck Index - 2006; p. 729 [58] Merck Index - 2006; p. 729 [59] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [60] FDA - Lexiva Prescribing Information, 03/05/08, p. 3. Available at: http://www.fda.gov/cder/foi/label/2008/021548s017,022116s001lbl.pdf. Accessed 01/19/09. [61] Merck Index - 2006; p. 729 [62] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 01/19/09. [63] Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection - MMWR 2002;51 (No.RR-7) Updated as a Living Document on July 29, 2008. Available at: http://aidsinfo.nih.gov/contentfiles/PediatricGuidelines.pdf. Accessed 01/19/09.
|